C-erbB-2

c-erbB-2 expression and prognosis of gastric cancer: a meta-analysis

Z. Q. Wang and Sun, B. J., c-erbB-2 expression and prognosis of gastric cancer: a meta-analysis, vol. 14, pp. 1782-1787, 2015.

The prognostic role of c-erbB-2 in gastric cancer is controversial. We conducted a meta-analysis to evaluate the relationship between c-erbB-2 expression and the prognosis of gastric cancer. We evaluated 20 published studies assessing the relationship between c-erbB-2 and gastric cancer prognosis. The Revman 5.0 software was used to perform literature retrieval, article selection, data collection, and statistical analysis. We utilized a fixed-effect model to pool hazard ratios and 95% confidence intervals from the studies.

Association of chemotactic factor receptor 5 gene with breast cancer

Y. Zhang, Meng, F. Y., Li, W. L., Zhou, C. X., Guan, Z., and Fan, H. Y., Association of chemotactic factor receptor 5 gene with breast cancer, vol. 12, pp. 5289-5300, 2013.

We designed a 2-stage study to investigate chemotactic factor receptor 5 (CCR5) gene expression in breast cancer tissues and axillary lymph nodes and analyze the association between the CCR5-Δ32 gene polymorphism and the clinical features and prognosis of breast cancer patients. The first stage examined 72 cases of invasive ductal carcinoma and axillary lymph node tissue, 50 cases of breast fibroadenoma tissue, and 40 cases of normal breast tissue.

Subscribe to C-erbB-2